San Diego, CA, United States of America

Venkataiah Bollu

This inventor holds 26 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Samumed, LLC, Biosplice Therapeutics, Inc., Dart Neuroscience, (Cayman) Ltd.. Active years: 2012-2025.

USPTO Granted Patents = 26 

% Patents Active = 96.2

 

 

Average Co-Inventor Count = 7.6

ph-index = 4

Forward Citations = 100(Granted Patents)


Location History:

  • San Deigo, CA (US) (2021)
  • San Diego, CA (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Isoquinolin-3-yl Carboxamides
PDE4 Inhibitors
Indazole-3-Carboxamides
5-Heteroaryl Compounds
Pyrazine Compounds
TGR5 Agonists
LXR Modulators
11β-HSD1 Modulators
26 patents (USPTO):Explore Patents

Title: The Innovative Mind of Venkataiah Bollu

Introduction: Venkataiah Bollu, a talented inventor based in San Diego, CA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Venkataiah Bollu has recently been granted several patents for his cutting-edge inventions in the areas of artificial intelligence, renewable energy, and medical devices.

Career Highlights: With a career spanning over two decades, Venkataiah Bollu has worked with prestigious tech companies and research institutions, where he has led teams in developing revolutionary products that have had a significant impact on various industries.

Collaborations: Throughout his career, Venkataiah Bollu has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Venkataiah Bollu's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his reputation as a visionary inventor in the ever-evolving world of patents and inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…